Universal Health Services, Inc. (NYSE:UHS) reported first-quarter revenue growth of 9.3% year-over-year to $3.29 billion, beating the consensus of $3.21…
Universal Health Services (NYSE:UHS) reported quarterly earnings of $2.15 per share which missed the analyst consensus estimate of $2.46 by 12.6 percent. This is a 11.89 percent decrease over earnings of $2.44 per share
Gainers
Vallon Pharmaceuticals, Inc. (NASDAQ: VLON) shares jumped 100.9% to close at $2.27 on Friday. Vallon Pharmaceuticals engaged Ladenburg Thalmann & Co Inc to evaluate strategic alternatives for the Company to maximize shareholder value.
Earlier today HCA Healthcare Inc (NYSE: HCA) reported Q1 earnings and cut FY22 guidance.
The revised outlook is based on current expectations regarding the impact of the COVID-19 pandemic and related government legislation, labor cost, and inflation.
If history is any guide, there may be good fortune ahead for shares of Universal Health Services (NYSE:UHS). A so-called "golden cross" has formed on its chart and, not surprisingly, this could be bullish for the stock.
Over the past 3 months, 5 analysts have published their opinion on Universal Health Services (NYSE:UHS) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.